Top

Published in:

01-03-2008 | REVIEW

Structural and functional imaging by MRI

Authors: René M. Botnar, PhD, Eike Nagel, MD

Published in: Basic Research in Cardiology | Issue 2/2008

Abstract

Magnetic resonance imaging is one of the most exciting techniques for noninvasive molecular imaging of the cardiovascular system. The article will describe challenges, solutions and results of magnetic resonance plaque imaging ex-vivo, in the experimental animal and in patients.

Albert TSE, Kim RJ, Judd RM (2006) Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol 101:383–390PubMedCrossRef

Botnar RM, Kim WY, Bornert P, Stuber M, Spuentrup E, Manning WJ (2001) 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 46:848–854PubMedCrossRef

Botnar RM, Stuber M, Lamerichs R, Smink J, Fischer SE, Harvey P, Manning WJ (2003) Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla. J Cardiovasc Magn Reson 5:589–594PubMedCrossRef

Cai JM, Hastukami TS, Ferguson MS, Small R, Polissar NL, Yuan C (2002) Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106:1368–1373PubMedCrossRef

Clarke SE, Beletsky V, Hammond RR, Hegele RA, Rutt BK (2006) Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke 37:93–97PubMedCrossRef

Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ (2001) Effects of lipid-lowering by simvastatin on human atherosclerotic lesions—a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104:249–252PubMedCrossRef

Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ (2005) Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions—a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46:106–112PubMedCrossRef

Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ (2002) Lipid lowering by simvastatin induces regression of human atherosclerotic lesions—two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106:2884–2887PubMedCrossRef

Corti R, Osende JI, Fallon JT, Fuster V, Mizsei G, Jneid H, Wright SD, Chaplin WF, Badimon JJ (2004) The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis—in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 43:464–473PubMedCrossRef

10.

Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R (1998) Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97:1802–1809PubMed

11.

Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ (2002) Progression and regression of atherosclerotic lesions—monitoring with serial noninvasive magnetic resonance imaging. Circulation 105:993–998PubMedCrossRef

12.

Itskovich VV, Samber DD, Mani V, Aguinaldo JGS, Fallon JT, Tang CY, Fuster V, Fayad ZA (2004) Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. Magn Reson Med 52:515–523PubMedCrossRef

13.

Jacoby C, Molojavyi A, Flogel U, Merx MW, Ding ZP, Schrader J (2006) Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice. Basic Res Cardiol 101:87–95PubMedCrossRef

14.

Jahnke C, Dietrich T, Paetsch I, Koehler U, Preetz K, Schnackenburg B, Fleck E, Graf K, Nagel E (2007) Experimental evaluation of the detectability of submillimeter atherosclerotic lesions in ex vivo human iliac arteries with ultrahigh-field (7.0 T) magnetic resonance imaging. Int J Cardiovasc Imaging 23:519–527PubMedCrossRef

15.

Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ (2001) In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 21:1556–1560PubMedCrossRef

16.

Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, Yuan C (2003) Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107:851–856PubMedCrossRef

17.

Kerwin WS, O’Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C (2006) Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241:459–468PubMedCrossRef

18.

Kim RJ, Chen EL, Lima JAC, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318–3326PubMed

19.

Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115:228–235PubMedCrossRef

20.

Koops A, Ittrich H, Petri S, Priest A, Stork A, Lockemann U, Adam G, Weber C (2007) Multicontrast-weighted magnetic resonance imaging of atherosclerotic plaques at 3.0 and 1.5 Tesla: ex-vivo comparison with histopathologic correlation. Eur Radiol 17:279–286PubMedCrossRef

21.

Lima JAC, Desai MY, Steen H, Warren WP, Gautam S, Lai SH (2004) Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110:2336–2341PubMedCrossRef

22.

Lygate CA, Schneider JE, Hulbert K, ten Hove M, Sebag-Montefiore LM, Cassidy PJ, Clarke K, Neubauer S (2006) Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res Cardiol 101:8–16PubMedCrossRef

23.

Maintz D, Ozgun M, Hoffmeier A, Fischbach R, Kim WY, Stuber M, Manning WJ, Heindel W, Botnar RM (2006) Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 27:1732–1736PubMedCrossRef

24.

Manke D, Nehrke K, Bornert P (2003) Novel prospective respiratory motion correction approach for free-breathing coronary MR angiography using a patient-adapted affine motion model. Magn Res Med 50:122–131CrossRef

25.

Martin AJ, Gotlieb AI, Henkelman RM (1995) High-resolution MR-imaging of human arteries. J Magn Reson Imaging 5:93–100PubMedCrossRef

26.

McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJM, Bell PRF, Naylor AR, Brindle NPJ (1999) Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology. J Vasc Surg 30:261–268PubMedCrossRef

27.

McConnell MV, Aikawa M, Maier SE, Ganz P, Libby P, Lee RT (1999) MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 19:1956–1959PubMed

28.

Niendorf T, Hardy CJ, Giaquinto RO, Gross P, Cline HE, Zhu YD, Kenwood G, Cohen S, Grant AK, Joshi S, Rofsky NM, Sodickson DK (2006) Toward single breath-hold whole-heart coverage coronary MRA using highly accelerated parallel imaging with a 32-channel MR system. Magn Reson Med 56:167–176PubMedCrossRef

29.

Nikolaou K, Becker CR, Muders M, Babaryka G, Scheidler J, Flohr T, Loehrs U, Reiser MF, Fayad ZA (2004) Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries. Atherosclerosis 174:243–252PubMed

30.

Takaya N, Yuan C, Chu BC, Saam T, Underhill H, Cai JM, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS (2006) Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events—a prospective assessment with MRI—initial results. Stroke 37:818–823PubMedCrossRef

31.

Toussaint JF, Southern JF, Fuster V, Kantor HL (1995) T-2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 15:1533–1542PubMed

32.

Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang HY, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta(3)-integrin-targeted nanoparticles. Circulation 108:2270–2274PubMedCrossRef

33.

Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, Brown BG (2001) Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI—a case-control study. Arterioscler Thromb Vasc Biol 21:1623–1629PubMedCrossRef

Title: Structural and functional imaging by MRI
Authors: René M. Botnar, PhD
Eike Nagel, MD
Publication date: 01-03-2008
Publisher: D. Steinkopff-Verlag
Published in: Basic Research in Cardiology / Issue 2/2008
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-008-0706-3

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Structural and functional imaging by MRI

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2008

18F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases

Combined imaging of molecular function and morphology with PET/CT and SPECT/CT: Image fusion and motion correction

Imaging of the heart with computed tomography

MR-optical imaging of cardiovascular molecular targets

Near-infrared fluorescent probes for imaging vascular pathophysiology

Ultrasonic imaging of molecular targets

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page